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Background
• Stroke is a major cause of death and long term illness
• 5% of UK population are affected, around 130 thousand 
suffer a new or recurrent stroke each year
• Common risk factors such as age, gender, smoking,
diabetes .., don’t account for all the stroke cases
• Emerging evidence shows that respiratory infections and 
incidence of strokes  may be related 
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Previous studies
 Contradictory evidence: Small study size
 Design Bias: recall, therapeutic
 Confounding: ‘healthy user effect’, missing 
different treatments and differences in health 
behaviours in vaccinees
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Study aim
To investigate association of influenza & 
pneumococcal vaccination with Stroke/TIA using 
General Practice Research Database (GPRD) to 
account for known confounders
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Method
•Vaccination season from 01 Sept 2001-31 Aug 2009
•Matched for age, sex, calendar time and practice
•Data is up-to-standard: patients are registered with the 
same practice for the study period. 
First recorded 
Stroke
47,216 Controls
47,216 Cases 
Flu VacPneumococcal  Vac Flu Vac
timeIndex date
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 ‘Case’: medical diagnostic Read/OXMIS codes for 
first stroke entered by GP
 ‘Index date’: first date when GP recorded 
stroke/TIA code (fatal/non-fatal) in clinical/referral 
record
 ‘Control’: age/sex/ calendar time/practice matched 
controls per case with index date corresponding to 
date of matched case
Method
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 STATA: conditional logistic regression
 Outcomes: unadjusted and adjusted odds ratios
 Factors considered for adjusted OR included 
– Vaccine risk groups: chronic heart (and other 
cardiovascular diseases); diabetes, asthma/COPD; chronic 
renal and liver disease; splenectomy; chronic neurological 
disease
– Other CHD risk factors: smoking status; hyperlipidaemia; 
BMI; family history of AMI; family history of stroke; 
hypertension; SBP; total cholesterol
Analysis
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Descriptive statistics
Cases (those with 
stroke/TIA)
N= 47,216 (%)
Controls
N= 47,216 (%)
Age (years):      Mean (SD)
95% CI
79.8 (13.4)
79.7 – 80.0
79.8 (13.4)
79.7 – 80.0
Aged under 65  years 23.2 23.2
Aged over 65 years 76.8 76.8
Gender: Male 48.0 48.0
Index period: Sep – Nov 
Dec – Mar 
April – Aug
24.6
33.9
41.5
--
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Vaccine risk groups Cases (those with 
stroke/TIA) 
N= 47,216  (%) 
Controls
N= 47,216 
(%)
p
Asthma/COPD attack ever 7,666 (16.2) 6,878 (14.6) <0.001
Chronic heart disease 11,778 (24.9) 8,121 (17.2) <0.001
Diabetes 5,787 (12.3) 4,133 (8.8) <0.001
Splenectomy 145 (0.3) 76 (0.2) <0.001
Chronic liver disease 179  (0.4) 90 (0.2) <0.001
Chronic renal disease 4,132 (8.8) 3,428 (7.3) <0.001
Chronic neurological 
disease
300 (0.6) 185 (0.4) <0.001
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Cardiovascular risk factors
Cases (those 
with stroke/TIA)
N= 47,216 
(%) 
Controls
N= 47,216 
(%)
P
Hyperlipidaemia 6,217(13.2) 5,180 (11.0) <0.001
Family history of 
myocardial infarction 
8,085 (17.1) 7,234 (15.3) <0.001
Family history of stroke 4,238 (9.0) 3,582 (7.6) <0.001
Body mass index recorded 
within past 5 years†
19097 (40.4) 17536 (37.1) <0.001
Body mass index kg/m2 
(mean [SD])
27.8 [5.0] 27.4 [4.8 ] <0.001
Peripheral vascular 
diseases
1,677 (3.6) 1,049 (2.2) <0.001
Hypertension 23,053 (48.8) 18,407 (39.0) <0.001
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Cardiovascular risk factors
Cases (those with 
stroke/TIA)
N= 47,216 (%) 
Controls
N= 47,216 
(%)
P
Latest Smoking history 
Never smoked 
Ex-smoker
Current smoker
Not recorded
18,508 (45.0)
18,556 (45.0)
3,361 (8.2)
684 (1.2)
19,878 (49.5)
16,037 (40.0)
2,646 (6.6)
1,574 (3.9)
<0.001
Aspirin uptake (≥ 2 
prescriptions in previous 6 
months)
5,112 (10.8) 2,151 (4.6) <0.001
Statin uptake (≥ 1 prescription 
in previous year)
7,714 (16.3) 3,814(8.1) <0.001
Antihypertensive treatment 
(≥ 1 prescription in previous year)
7,034 (14.9) 5,313 (11.3) <0.001
Oral anticoagulant (≥ 1 
prescription in previous year)
1,308 (2.8) 630 (1.3) <0.001
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Cardiovascular risk 
factors
Cases (those with 
stroke/TIA)
N= 47,216 (%) 
Controls
N= 47,216 
(%)
P
GP surgery Consultations
≤12
13-26
27-44
≥45
12278 (26.0)
11692 (24.8)
11126 (23.6)
12120 (25.7)
16241 (34.4)
12249 (25.9)
9717 (20.6)
9009 (19.1)
<0.001
Charlson index
0
1
2
3
4
≥5
16258 (34.4)
8985 (19.0)
6981 (14.8)
4680 (9.9)
3201 (6.8)
25414 (53.8)
7085 (15.0)
5640 (12.0)
2989 (6.3)
2166 (4.6)
<0.001
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Main results
Timing of 
Vaccination
Cases
N(%)
Controls
N(%)
Adjusted
OR 95% CI
Same season as 
index date 24,819 
(52.6)
23,974 
(50.8)
0.90 0.87 – 0.93
Early within-
season (Sept. to 
mid-Nov.)
21,880 
(46.3)
21,383 
(45.3)
0.88 0.85 – 0.92
Late within-
season (mid-
Nov. to Feb.)
2,939 
(6.2)
2,591  
(5.5)
1.04 0.97 – 1.11
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Main results
Timing of 
Vaccination
Age 
(yrs)
Cases
N(%)
Controls
N(%)
Adjusted
OR 95% CI
Within 
season
≤64 2,239 
(20.5)
1,472 
(13.5)
0.92 0.83  – 1.01
≥65 22,580 
(62.3)
22,502 
(62.0)
0.89 0.85  – 0.92
Early 
within-
season
≤64 1,813 
(16.6)
1,182 
(10.8)
0.93 0.84  – 1.03
≥ 65 20,201  
(55.7)
20,067 
(55.3)
0.87 0.83  – 0.91
www.lincoln.ac.uk
Main results
Timing of 
Vaccination
Age
(yrs)
Cases
N(%)
Controls
N(%)
Adjusted
OR 95% CI
Late 
within-
season 
≤64 426 
(3.9)
290
(2.7)
0.87 0.73  – 1.05
≥ 65 12,513 
(6.9)
2,301  
(6.3)
1.02 0.95  – 1.09
www.lincoln.ac.uk
Main results: pneumococcal 
vaccine 
Age (yrs) Cases
N(%)
Controls
N(%)
Adjusted*
OR 95% CI
All ages 23,306 
(49.4)
21,856 
(46.3)
0.98 0.94 – 1.02
<65 years
1,782  
(16.3)
1,013 
(9.3)
0.96 0.95 – 1.07**
≥ 65 
years
21,524 
(59.3)
20,843  
(57.5)
1.00 0.95 – 1.03
* Adjusted for influenza vaccination as well
** After sensitivity analysis for unmeasured confounder 
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Study strengths and limitations
 Large GPRD dataset, no problems with recall bias.
 Charslon index, GP home visits (frailty) with many 
more confounders accounted for.
 Sensitivity analysis done to complement the 
findings. 
 Residual confounding (unknown factors)
 ‘Healthy vaccination’ bias
 Inadequate patient data on GPRD due to practice 
transfers
 Incomplete recording of blood pressure, cholesterol 
levels, BMI, etc. on the GPRD
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Conclusions
 Influenza vaccination is associated with reduced risk of 
stroke/TIA
– 10% reduction in risk of over all  stroke/TIA 
– adjusted OR 0.90; 95% CI 0.87 to 0.93 
 Early influenza seasonal vaccination (September to mid-
November) associated with lower risk of stroke/TIA than 
later vaccination (mid-November to January):
– Early Over 65’s: 13% reduction in risk of stroke/TIA 
– adjusted OR 0.87; 95% CI 0.83 to 0.91 
– This was significant after sensitivity analysis.
 Pneumococcal vaccination was not associated with a 
reduction in risk of stroke after sensitivity analysis for 
unmeasured confounding (frailty)
– OR 0.96; 95% CI (0.95 – 1.07)  
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